SCHEMBL5741808

SCHEMBL5741808

Nc1nc(Nc2ccc3nc(-c4ccccc4F)cc(N)c3c2)cc(-c2ccc(C(F)(F)F)cc2)n1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 5/20 0.50
AGPAT2 O15120 2/20 0.48
ROCK2 O75116 5/20 0.43
ACP1 P24666 1/20 0.42
EPHX2 P34913 1/20 0.40
TRPV1 Q8NER1 1/20 0.40
AURKA O14965 1/20 0.40
PDPK1 O15530 1/20 0.40
TGFBR1 P36897 1/20 0.40
ROCK1 Q13464 1/20 0.40
AURKB Q96GD4 1/20 0.40
CYP3A4 P08684 1/20 0.38
TOP1 P11387 1/20 0.38
KDM4E B2RXH2 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TP53 P04637 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5741794 1.00 MCHR1 (0.50) MCHR1AGPAT2ROCK2ACP1EPHX2
SCHEMBL5743241 0.91 AGPAT2 (0.53) MCHR1AGPAT2ROCK2AURKAPDPK1
SCHEMBL5744514 0.91 AGPAT2 (0.47) MCHR1AGPAT2ROCK2ACP1AURKA
SCHEMBL5740529 0.90 MCHR1 (0.53) MCHR1AGPAT2ROCK2ACP1TRPV1
SCHEMBL5740563 0.90 AGPAT2 (0.52) MCHR1AGPAT2ROCK2ACP1TRPV1
SCHEMBL5742912 0.89 AGPAT2 (0.59) AGPAT2ROCK2ACP1AURKAPDPK1
SCHEMBL5742005 0.89 AGPAT2 (0.59) AGPAT2ROCK2ACP1AURKAPDPK1
SCHEMBL5740460 0.88 MCHR1 (0.50) MCHR1AGPAT2ROCK2ACP1TRPV1
SCHEMBL5741580 0.88 ACP1 (0.48) MCHR1AGPAT2ROCK2ACP1HSD17B10
SCHEMBL5740849 0.86 MCHR1 (0.51) MCHR1AGPAT2ROCK2ACP1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1339706-B1 N-TYPE CALCIUM CHANNEL ANTAGONISTS FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2006-04-19 EP disclosed